Skip links

Blog

recent-fda-committee-vote-could-speed-multiple-myeloma-drug-approval

Recent FDA committee vote could speed multiple myeloma drug approval

MIAMI, FLORIDA (May 21, 2024) – A U.S. Food and Drug Administration committee voted unanimously in April to approve a new clinical endpoint, minimal residual disease (MRD), when evaluating proposed drugs to treat multiple myeloma. Credit: Photo by Sylvester MIAMI, FLORIDA (May 21, 2024) –
treatment-options-for-hepatocellular-carcinoma-using-immunotherapy:-present-and-future

Treatment options for hepatocellular carcinoma using immunotherapy: present and future

Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms. The tumor microenvironment plays a pivotal role in fostering immune suppression and maintaining self-tolerance, which are crucial in developing and refining immunotherapy approaches. Credit:
germicidal-lamps-using-uv-c-radiation-may-pose-health-safety-issues

Germicidal lamps using UV-C radiation may pose health safety issues

“Despite the potential advantages of utilizing UV-C radiation for deactivating pathogens such as SARS-CoV-2, the prevailing conclusion remains that UV-C radiation poses concurrent risks to human health.” Credit: 2024 Alessio et al. “Despite the potential advantages of utilizing UV-C radiation for deactivating pathogens such as
inhibitory-effect-of-mir-377-on-prostate-cancer-cells

Inhibitory effect of miR-377 on prostate cancer cells

“Our research findings suggest that miR-377 could potentially serve as a valuable therapeutic strategy for the treatment of prostate cancer (PCa).” Credit: 2024 Azimi et al. “Our research findings suggest that miR-377 could potentially serve as a valuable therapeutic strategy for the treatment of prostate
age,-race-impact-ai-performance-on-digital-mammograms

Age, race impact AI performance on digital mammograms

OAK BROOK, Ill. – In a study of nearly 5,000 screening mammograms interpreted by an FDA-approved AI algorithm, patient characteristics such as race and age influenced false positive results. The study’s results were published today in Radiology, a journal of the Radiological Society of North
oncology-events-in-poland-solidify-collaboration-with-nccn

Oncology events in Poland solidify collaboration with NCCN

WARSAW, POLAND [May 21, 2024] — The National Comprehensive Cancer Network® (NCCN®)—a global nonprofit responsible for leading cancer treatment guidelines—is taking part in two events in Warsaw focused on advancing cancer care and highlighting the Poland-US bilateral achievements in health care from May 21-22, 2024.
pancreatic-cancer-research-receives-$8m-philanthropic-funding-boost

Pancreatic cancer research receives $8m philanthropic funding boost

An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research centre at WEHI. Credit: WEHI An exceptional $8 million, 10-year philanthropic investment will spearhead new treatments for pancreatic cancer and create a new dedicated research
Explore
Drag